About Madopar (Prescription Drug)
Madopar is an international brand name for the combination of levodopa and benserazide. Levodopa, a precursor molecule to dopamine, is an important neurotransmitter implicated in the underlying cause of Parkinson's disease. Benserazide allows levodopa to continue circulating in the body longer.
Learn more about Madopar in our Madopar Community Report.
|185 mg Daily Dec 12 - 20, 2008|
|750 mg Daily Dec 20 - 24, 2008|
|1500 mg Daily Dec 24, 2008 - Jan 18, 2009|
|Stopped Did not seem to work Jan 18, 2009|
Jan 9, 2009
EffectivenessSlight (for stiffness/spasticity)
Side effectsModerate (sickness)
BurdenSomewhat hard to take